AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

Samvardhana Motherson, Garden Reach Shipbuilders, NLC India and Central Bank of India are also among the stocks to watch in ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

A significant chunk of revenue for most Indian generic drugmaker comes from the U.S. and fierce competition in the North ...

Cipla's product portfolio spans complex generics as well as drugs in the respiratory anti-retroviral urology cardiology anti-infective CNS and various other key therapeutic segments. With a rich ...

Stay up-to-date with the Cipla Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...

Domestic equity benchmarks Nifty 50 and Sensex fell about half a per cent on Monday, as selling pressure in energy and FMCG ...

Cipla Q3 Profit Surges 49% to Rs 1,571 Crore Cipla's net profit for Q3 FY25 jumped 49% to Rs 1,571 crore, driven by growth across markets. Revenue rose to Rs 7,073 crore. Read more. Jan 28, 2025 16:23 ...

Budget 2025 boosts healthcare with Rs 98,311 crore allocation, expanding medical education and cancer care while easing drug costs. Pharma stocks gain momentum amid duty cuts and PLI incentives.